Ignite Creation Date:
2024-05-06 @ 8:40 AM
Last Modification Date:
2024-10-26 @ 12:03 PM
Study NCT ID:
NCT02795325
Status:
TERMINATED
Last Update Posted:
2024-07-11
First Post:
2016-05-18
Brief Title:
A Study of DCR-PH1 in Patients With Primary Hyperoxaluria Type 1 PH1
Sponsor:
Dicerna Pharmaceuticals Inc a Novo Nordisk company
Organization:
Novo Nordisk AS
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-05-13
Start Date Type:
ACTUAL
Primary Completion Date:
2016-10-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-10-14
Completion Date Type:
ACTUAL
First Submit Date:
2016-05-18
First Submit QC Date:
June 6 2016
Study First Post Date:
2016-06-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-10
Last Update Post Date:
2024-07-11
Last Update Post Date Type:
ACTUAL